ClinConnect ClinConnect Logo
Search / Trial NCT04482179

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease

Launched by UNIVERSITY OF PENNSYLVANIA · Jul 17, 2020

Trial Information

Current as of October 15, 2025

Completed

Keywords

ClinConnect Summary

TMS is a technique by which a brief electrical current is induced in brain tissue causing a brief suppression of the excitability of the underlying tissue; the technique, which was introduced in the 1980s and has been extensively used around the world, has been shown to transiently improve or disrupt specific cognitive operations. To achieve this end, a coil is positioned against the subject's head. The delivery of a single pulse begins with the discharge of current from a capacitor into a circular or figure-of-eight coil; this electrical current generates a brief magnetic field of up to 2....

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A diagnosis of mild-moderate AD as defined by the National Institute of Aging - Alzheimer's Disease and Related Disorders Association criteria
  • Mild-moderate cognitive impairment, indicated by Mini-Mental Status Exam (MMSE) scores between 23 and 15 inclusive
  • Must be right handed as defined by the Edinburgh Handedness Inventory
  • Must be a native English speaker
  • Must be able to understand the nature of the study, and give informed consent
  • Exclusion Criteria:
  • History of stroke
  • History of seizure
  • History of any other significant neurologic disease (e.g., ALS)
  • Significant depression as defined by the Geriatric Depression Scale.
  • Any significant medical disorder that, in the view of the investigators, could threaten the subject's ability to complete the study (e.g., cancer, significant cardiac disease)
  • Any contraindications to TMS, including uncontrolled seizures, previous brain surgery, and history of tinnitus

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

H. Branch Coslett, MD

Principal Investigator

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials